James B. Renacci sold ABIOMED INCORPORATED (ABMD) (ABMD)
James B. Renacci (R-OH), a U.S. Representative, has disclosed 4 trades in ABIOMED INCORPORATED (ABMD) (ABMD) since 2015, 3 purchases and 1 sale, worth an estimated $448K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: James B. Renacci sold $15,001 - $50,000 of ABIOMED INCORPORATED (ABMD) (ABMD) on September 15, 2017. Since that trade, ABMD is up +0.00% against the S&P 500 up +234.30%, an outperformance of -234.30%.
Across these filings, James B. Renacci has been a net buyer of ABMD (a buy-to-sell ratio of 3.00). The most recent disclosed ABMD transaction shown was dated November 15, 2017. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
James B. Renacci's ABMD trades vs the price
ABMD is up +0.00% since James B. Renacci sold on September 15, 2017, versus +234.30% for the S&P 500.
Performance since this trade
All James B. Renacci ABMD trades
| Traded | Type | Size | Return | Est. profit | |
|---|---|---|---|---|---|
| November 15, 2017 | BUY | $250,001 - $500,000 | N/A | — | |
| September 15, 2017 | SELL | $15,001 - $50,000 | N/A | — | |
| October 29, 2015 | BUY | $1,000 - $15,000 | N/A | — | |
| July 27, 2015 | BUY | $15,001 - $50,000 | N/A | — |
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
James B. Renacci & ABMD trading FAQ
Is it legal for James B. Renacci to trade ABIOMED INCORPORATED (ABMD) (ABMD) stock?
Yes. Members of Congress are allowed to trade individual stocks, including ABIOMED INCORPORATED (ABMD) (ABMD), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did James B. Renacci sell ABMD?
James B. Renacci disclosed a sale of $15,001 - $50,000 of ABIOMED INCORPORATED (ABMD) (ABMD) on September 15, 2017, according to public STOCK Act filings.
How has ABMD performed since James B. Renacci's trade?
Since James B. Renacci sold ABMD on September 15, 2017, the stock is up +0.00%, versus +234.30% for the S&P 500 over the same period, an outperformance of -234.30%.
How many times has James B. Renacci traded ABMD?
James B. Renacci has disclosed 4 ABMD trades since 2015 (3 purchases and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional ABMD trades?
Quantellect tracks every disclosed congressional trade in ABIOMED INCORPORATED (ABMD) (ABMD) on the ABIOMED INCORPORATED (ABMD) congressional trading page, which aggregates filings across all members of Congress.
James B. Renacci's ABMD tradesAll congressional filings for ABIOMED INCORPORATED (ABMD)James B. Renacci's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.